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It is a well-established fact that in silico enzyme engineering approaches such as molecular modeling, docking, 
simulation, provide molecular level understanding of the function of biocatalyst and specifically the role of 
mutational sites. These standalone protocols deliver the understanding of either Michaelis complex formation or 
the transition state formation or entry/exit path of the substrate. However, an intelligent workflow of these 
protocols can be applied for not only engineering of enzymes but to design them in silico. Quantumzyme has 
developed QZyme WorkbenchTM, an integrated workflow using open source computational methods and 
proprietary scripts for scanning all the events involved in the biocatalytic process. The aim of this workbench is 
to conduct in silico protein design and is routinely leveraged to engineer enzyme for achieving desirable 
functions.  
 
In the current study, we implemented our workbench to engineer a short chain dehydrogenase/reductase 
(SmSDR) enzyme to prepare R-Phenylephrine (R-PE) via stereoselective reduction of 1-(3-hydroxyphenyl)-2-
(methylamino) ethanone. R-PE is one of the commonly used pharmaceutical analogs of Adrenalins. In order to 
avoid extreme conditions required for chemical methods, an optimal solution is to introduce an enzyme which 
exhibits high activity, and enantioselectivity to accomplish the asymmetric reduction step to yield enantiopure R-
PE. Several such engineered enzymes are available for the synthesis of different biologically active compounds. 
In the present work, we have engineered a variant of SDRs enzyme to have high activity and enantio-specificity, 

















Figure 1 – Enzymatic reduction scheme of 
HPMAE to R-PE 
 
Figure 2 – Active site of SmSDR for the 
enzymatic reduction of HPMAE to R-PE 
 
